Peter Madsen — ASN Events
  1. Schedule
  2. Peter Madsen

Peter Madsen

Novo Nordisk A/S, DENMARK, Denmark

  • This delegate is presenting an abstract at this event.
Presentations this author is a contributor to:

Insulin fatty acid acylation scan: Discovery of Insulin 327, an acylated hepato-preferential insulin analogue with high insulin receptor affinity (#173)

7:30 PM
Peter Madsen
Poster Session 2 and Drinks